China Biopharma Signs Marketing Agreement With Beijing Keyuan
Posted on: Thursday, 27 March 2008, 12:00 CDT
China Biopharma has reached agreement with Beijing Keyuan Xinhai Pharmaceutical to launch newly approved pharmaceutical products made by international pharmaceutical companies.
According to the agreement, China Biopharma will distribute pharmaceutical products made by international companies including human vaccines in China using its sales network and distribution logistics.
In order to effectively conduct its business operation and change from its passive marketing approach in China, the company has shifted its market strategy to working more closely with new pharmaceutical products from global leading pharmaceutical companies in addition to local products.
Qiumeng Wang, COO of China Biopharma, said: "We are very excited about the agreement we have reached with Beijing Keyuan Xinhai Pharmaceutical. It will significantly improve our current operation situation."
Source: Datamonitor
Related Articles
- Preformed Line Products Announces Agreement To Acquire Dulmison Business From Tyco Electronics
- Yingli Green Energy Becomes the First China-Based Company to Join PV CYCLE
- Aires Pharmaceuticals Signs Technology License Agreement With NIH
- An Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner With Chinese Pharmaceutical Companies
- Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
- Heritage and Banner Enter Into Generic Product Licensing Agreement
- China Organic Executes Agreement for Strategic Partnership With Xinmiao to Significantly Contribute to Revenues and Earnings
- ONEOK Sells Its Oil and Gas Production Companies
- Cooper Tire & Rubber Company Forms Joint Venture With Saiyang Sealing Products Company of China
- DataMEG Corp. Subsidiary NECI Signs Exclusive Pacific Rim Product-Distribution Agreement
 |
 |
User Comments (0)
RSS Feeds